You are here

  • Home
  • Archive
  • Volume 20, Issue 2
  • Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

Article metrics

Article menu
Download PDFPDF
Economic analysis
Randomised controlled trial
Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

 

Online download statistics by month:

Online download statistics by month: January 2015 to March 2024

AbstractFullPdf
Jan 2015971618
Feb 2015505027
Mar 2015157317
Apr 201511368
May 20155769
Jun 20152433
Jul 20153311
Aug 20151912
Sep 20151901
Oct 20151821
Nov 20152022
Dec 20154000
Jan 20162900
Feb 20162323
Mar 2016300
Apr 2016602
May 20164910
Jun 20161504
Jul 20161000
Aug 20161200
Sep 20162343
Oct 20164433
Nov 20164710
Dec 2016922
Jan 20172711
Feb 20171600
Mar 2017921
Apr 2017922
May 20171210
Jun 20171133
Jul 20171000
Aug 20171822
Sep 20172000
Oct 20172912
Nov 20173211
Dec 20172000
Jan 20183511
Feb 20182632
Mar 20183171
Apr 20181910
May 20182500
Jun 20183710
Jul 20183301
Aug 20185300
Sep 20182600
Oct 20185121
Nov 20184421
Dec 20185310
Jan 20196632
Feb 20194911
Mar 20195310
Apr 20191600
May 2019800
Jun 20192320
Jul 20193410
Aug 20191820
Sep 20193820
Oct 20193812
Nov 20194911
Dec 20193112
Jan 20202941
Feb 20201900
Mar 2020200
Apr 2020400
May 20201405
Jun 20201200
Jul 20201000
Aug 2020601
Sep 20202800
Oct 2020800
Nov 2020500
Dec 20201800
Jan 20212000
Feb 20211200
Mar 20211000
Apr 2021200
May 2021111
Jul 2021110
Aug 2021311
Sep 2021320
Oct 2021900
Nov 20211600
Dec 20212100
Jan 20222103
Feb 20222221
Mar 20222800
Apr 20221200
May 20223800
Jun 20224520
Jul 20221910
Aug 20224110
Sep 20222700
Oct 20224000
Nov 20221800
Dec 20221200
Jan 20231200
Feb 20235100
Mar 2023200
Apr 2023200
May 20231910
Jul 20231000
Aug 2023900
Sep 2023600
Oct 20231000
Nov 20232700
Dec 20231620
Jan 20241211
Feb 20241100
Mar 20242000
Total2769168147